Closed To Recruitment

  1. SINFONIA
    A clinical trial examining the benefits of SingINg For breathing in COPD aNd ILD pAtients.
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient and Carer Trial Phase: Phase 3 Trial Location: NSW VIC Trial Status: Closed to recruitment Trial Type: Observational
  2. Novartis LTP001
    A participant and investigator-blinded, randomized, placebo-controlled, multicentre, platform study to investigate efficacy, safety, and tolerability of various single treatments in participants with idiopathic pulmonary fibrosis.
    Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Location: NSW QLD VIC WA Trial Status: Closed to recruitment Trial Type: Interventional
  3. BI 1305-0013
    A randomised, double-blind, placebo-controlled parallel group study in IPF patients over 12 weeks evaluating efficacy, safety and tolerability of BI 1015550 taken orally.
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Location: NSW Trial Status: Closed to recruitment Trial Type: Interventional
  4. STARSCAPE WA42293
    A phase III randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of PRM-151 in patients with Idiopathic Pulmonary Fibrosis.
    Trial Age Group: Over 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 3 Trial Location: NSW Trial Status: Closed to recruitment Trial Type: Interventional
  5. GALACTIC-1
    A randomised, double-blind, multicentre, parallel, placebo-controlled Phase 2b study in participants with idiopathic pulmonary fibrosis (IPF) investigating the efficacy and safety of GB0139, an inhaled galectin-3 inhibitor administered via a dry powder inhaler (DPI) over 52 weeks.
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Location: NSW Trial Status: Closed to recruitment Trial Type: Interventional
  6. Endeavour Biomedicines ENV-101
    A phase 2, multi-center study evaluating the safety and efficacy of ENV-101 (taladegib) in subjects with idiopathic pulmonary fibrosis (IPF).
    Trial Age Group: Over 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW Trial Status: Closed to recruitment Trial Type: Interventional
  7. Boehringer Ingelheim BI 1305-0014
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Location: NSW Trial Status: Closed to recruitment Trial Type: Interventional
  8. Lassen Therapeutics 1 LASN01
    A Phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to determine the safety, tolerability, immunogenicity and pharmacokinetic properties of LASN01 in healthy subjects and in patients with idiopathic pulmonary fibrosis or thyroid eye disease.
    Trial Age Group: Over 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 1 Trial Location: QLD VIC Trial Status: Closed to recruitment Trial Type: Interventional
  9. BI 1305-0023
    A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1305-0023 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
    Trial Age Group: Over 18 years Trial Disease Type: Progressive Fibrosing Interstitial Lung Diseases (PF-ILD) Trial Participant Type: Patient Trial Location: NSW Trial Status: Closed to recruitment Trial Type: Interventional
  10. HIIT
    High intensity interval training in fibrotic interstitial lung disease
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: NSW VIC Trial Status: Closed to recruitment Trial Type: Interventional